New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
10:51 EDTFDO, COV, IGT, BIIB, SHPG, NVDA, TIBX, CZR, OREX, ESIOptions with increasing implied volatility
Options with increasing implied volatility: ESI OREX CZR NVDA TIBX SHPG BIIB IGT COV FDO
News For ESI;OREX;CZR;NVDA;TIBX;SHPG;BIIB;IGT;COV;FDO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 12, 2015
19:33 EDTOREXOrexigen provides update on Contrave collaboration with Takeda
Subscribe for More Information
19:32 EDTOREXOrexigen provides statement on termination of Light Study
Subscribe for More Information
17:54 EDTOREXOn The Fly: After Hours Movers
Subscribe for More Information
17:52 EDTOREXTakeda requesting Orexigen to pay cost of second heart trial, Bloomberg says
Subscribe for More Information
16:25 EDTESIOn The Fly: Top stock stories for Tuesday
Stocks began the session deep in negative territory as bond yields in Europe and the U.S. were moving higher. The market saw its lows shortly after the open and soon began to recapture some of its losses. By noon, the losses were cut in half and the Dow made it all the way back to positive ground by the afternoon. Unable to gather any upside momentum, the rally stalled and the averages limped into the close. ECONOMIC EVENTS: In the U.S., the National Federation of Independent Business' small business optimism rose 1.7 points to 96.9 in April, versus expectations for a 96.0 reading. The JOLTs report showed job openings fell 150K to 4.99M in March, versus expectations for 5.11M openings. The 10-year U.S. Treasury yield climbed at high as 2.37% earlier in the session, which was its highest intraday mark since last November, before easing back by midday. Outside of the U.S., bond yields surged on 10-year notes in Japan, Italy, Spain, Portugal, and Germany. COMPANY NEWS: Shares of AOL (AOL) advanced $7.93, or 18.62%, to $50.52 after Verizon (VZ) agreed to buy the company for $50 per share in a deal valued at $4.4B. Verizon's John Stratton, speaking at the Jefferies 2015 Global TMT Conference, said the AOL deal was primarily about ad technology and Re/code reported that "one scenario" the service has heard about is that Verizon plans to spin off some or all of the content operations it is acquiring by buying AOL, such as the Huffington Post. Yahoo (YHOO) also rose 24c, or 0.55%, to $43.84, as Cantor Fitzgerald analyst Youssef Squali said he now views it as the "last remaining large scale digital media company of its kind." MAJOR MOVERS: Among the notable gainers was Pall Corp. (PLL), which advanced $19.31, or 19.44%, to $118.62 after The Wall Street Journal reported that the company is near a possible sale and listed Danaher (DHR) and Thermo Fisher (TMO) as potential buyers. Also higher was Pain Therapeutics (PTIE), which gained 68c, or 35.05%, to $2.62 after announcing that a study of its lead drug candidate, that is specifically designed to discourage certain common methods of drug tampering and misuse, demonstrated with statistical significance that both intact and chewed Remoxy were less "liked" than immediate-release oxycodone on the two primary endpoints of Drug Liking and Drug High. Among the noteworthy losers was ITT Educational Services (ESI), which plunged $1.75, or 43.53%, to $2.27 after the SEC announced that it had charged the company, along with its CEO and CFO, with fraud. Also lower were shares of NewLink Genetics (NLNK), which dropped $15.59, or 29.9%, to $36.55 after stating that it would continue its flagship IMPRESS trial as planned despite disclosing the FDA did not endorse management's plan to change the statistical analysis plan as defined in the original protocol. INDEXES: The Dow fell 36.94, or 0.2%, to 18,068.23, the Nasdaq slid 17.38, or 0.35%, to 4,976.19, and the S&P 500 dropped 6.21, or 0.29%, to 2,099.12.
15:17 EDTOREXOrexigen weakness a buying opportunity, says Piper Jaffray
Subscribe for More Information
12:42 EDTESIOptions with increasing put volume and implied volatility
Options with increasing put volume and implied volatility: ESI VIPS WETF
12:42 EDTESIITT Educational disagrees with SEC position
Subscribe for More Information
12:37 EDTESIFor-profit education stocks slide after SEC charges ITT with fraud
Subscribe for More Information
11:32 EDTESIITT Educational down 45% after SEC announces fraud charges against company
10:23 EDTESISEC announces fraud charges against ITT Educational Services
Subscribe for More Information
08:38 EDTOREXTakeda and Orexigen accept recommendation of the ESC
Subscribe for More Information
07:52 EDTSHPGLeerink to hold a tour
Subscribe for More Information
May 11, 2015
07:26 EDTNVDAQualcomm rivals questioned by EU antitrust regulators, Reuters reports
Antitrust regulators in the EU are asking Qualcomm's (QCOM) rivals about the company's business practices, Reuters reports, citing a document. Europe has been investigating Qualcomm for the last seven months over the way it licenses its products and its power over patents. Another EU inquiry, which began in 2010, was triggered by a complained from Nvidia's (NVDA) Icera unit over rebates and incentives. Reference Link
May 8, 2015
11:57 EDTNVDANVIDIA shares lower after reporting Q1 results amid soft PC demand
Subscribe for More Information
10:13 EDTNVDANVIDIA falls after earnings
Subscribe for More Information
10:01 EDTNVDAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:47 EDTSHPGLeerink's specialty pharma/generics analyst has analyst/industry conference call
Specialty Pharmaceuticals/Generics Analyst Gerberry discuss the future of dry eye treatment and the data and outlook for pipeline agents Shire's Lifitegrast and Eleven Biotherapeutics' EBI-005 and expectations for Actavis' Restasis use, assuming future approval of one or more pipeline agents, on an Analyst/Industry conference call to be held on May 12 at 10:30 am.
08:06 EDTNVDANVIDIA downgraded to Neutral from Buy at Roth Capital
Roth Capital downgraded NVIDA to Neutral from Buy and lowered its price target to $22 from $26. NVIDIA reported Q1 results below Roth's estimates and provided a cautious near-term outlook. Roth lowered estimates due to weak PC OEM low/mid-range graphics demand and weak Tegra mobile demand, combined with macro weakness and FX issues impacting enterprise workstation demand.
07:08 EDTOREXOrexigen reports Q1 EPS (14c), consensus (14c)
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use